share_log

Investors Can Find Comfort In China Medical System Holdings' (HKG:867) Earnings Quality

Investors Can Find Comfort In China Medical System Holdings' (HKG:867) Earnings Quality

投资者可以在中国医疗系统控股(HKG:867)的盈利质量中找到安慰
Simply Wall St ·  09/06 18:07

The market was pleased with the recent earnings report from China Medical System Holdings Limited (HKG:867), despite the profit numbers being soft. Our analysis suggests that investors may have noticed some promising signs beyond the statutory profit figures.

尽管利润数字疲软,但市场对中国医疗控股有限公司(HKG: 867)最近的收益报告感到满意。我们的分析表明,除了法定利润数字外,投资者可能已经注意到一些令人鼓舞的迹象。

big
SEHK:867 Earnings and Revenue History September 6th 2024
SEHK: 867 收益和收入历史记录 2024 年 9 月 6 日

How Do Unusual Items Influence Profit?

不寻常的物品如何影响利润?

Importantly, our data indicates that China Medical System Holdings' profit was reduced by CN¥233m, due to unusual items, over the last year. While deductions due to unusual items are disappointing in the first instance, there is a silver lining. We looked at thousands of listed companies and found that unusual items are very often one-off in nature. And that's hardly a surprise given these line items are considered unusual. Assuming those unusual expenses don't come up again, we'd therefore expect China Medical System Holdings to produce a higher profit next year, all else being equal.

重要的是,我们的数据表明,由于异常项目,中国医疗系统控股的利润比去年减少了23300万元人民币。尽管由于不寻常项目而产生的扣除首先令人失望,但有一线希望。我们调查了数千家上市公司,发现不寻常的物品本质上往往是一次性的。鉴于这些单列项目被认为不寻常,这并不奇怪。假设这些不寻常的支出不会再次出现,因此,在其他条件相同的情况下,我们预计中国医疗控股公司明年将实现更高的利润。

That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.

这可能会让你想知道分析师对未来盈利能力的预测。幸运的是,您可以单击此处查看根据他们的估计描绘未来盈利能力的交互式图表。

Our Take On China Medical System Holdings' Profit Performance

我们对中医控股盈利表现的看法

Unusual items (expenses) detracted from China Medical System Holdings' earnings over the last year, but we might see an improvement next year. Because of this, we think China Medical System Holdings' earnings potential is at least as good as it seems, and maybe even better! On the other hand, its EPS actually shrunk in the last twelve months. The goal of this article has been to assess how well we can rely on the statutory earnings to reflect the company's potential, but there is plenty more to consider. Keep in mind, when it comes to analysing a stock it's worth noting the risks involved. You'd be interested to know, that we found 2 warning signs for China Medical System Holdings and you'll want to know about these.

去年,不寻常的项目(支出)减少了中国医疗控股的收益,但明年我们可能会看到改善。正因为如此,我们认为中医控股的盈利潜力至少和看上去一样好,甚至可能更好!另一方面,其每股收益实际上在过去十二个月中萎缩了。本文的目标是评估我们在多大程度上可以依靠法定收益来反映公司的潜力,但还有很多需要考虑的地方。请记住,在分析股票时,值得注意所涉及的风险。你可能会有兴趣知道,我们发现了中国医疗控股公司的两个警告信号,你会想知道这些信号的。

This note has only looked at a single factor that sheds light on the nature of China Medical System Holdings' profit. But there is always more to discover if you are capable of focussing your mind on minutiae. For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying. While it might take a little research on your behalf, you may find this free collection of companies boasting high return on equity, or this list of stocks with significant insider holdings to be useful.

这份报告只研究了揭示中医控股利润性质的单一因素。但是,如果你能够将注意力集中在细节上,总会有更多的事情需要发现。例如,许多人认为高股本回报率是有利的商业经济的标志,而另一些人则喜欢 “关注资金”,寻找内部人士正在买入的股票。虽然可能需要你进行一些研究,但你可能会发现这份免费收集的拥有高股本回报率的公司,或者这份拥有大量内幕持股的股票清单很有用。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有反馈吗?对内容感到担忧吗?请直接联系我们。或者,也可以发送电子邮件至编辑团队 (at) simplywallst.com。
Simply Wall St的这篇文章本质上是笼统的。我们仅使用公正的方法根据历史数据和分析师的预测提供评论,我们的文章无意作为财务建议。它不构成买入或卖出任何股票的建议,也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意,我们的分析可能不考虑最新的价格敏感型公司公告或定性材料。简而言之,华尔街没有持有任何上述股票的头寸。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发